Molecular Formula | C18H29N3O6 |
Molar Mass | 383.44 |
Density | 1.267±0.06 g/cm3(Predicted) |
Boling Point | 728.9±60.0 °C(Predicted) |
Solubility | Soluble in methanol at 1mg/ml. Also soluble in DMSO or ethanol. |
Appearance | solid |
pKa | 3.43±0.20(Predicted) |
Storage Condition | -20°C |
In vitro study | CA-074 is a synthetic analogue of E-64, a natural peptidyl epoxide that irreversibly inhibits most known lysosomal cysteine proteinases, and is developed by means of rational drug design, exploiting the dipeptidylcarboxypeptidase activity of cathepsin B. CA-074 can be used to selectively inhibit cathepsin B within living cells, as long as the experimental conditions permit significant fluid-phase endocytosis of the drug. CA-074 inhibits cathepsin B with a K i of 2 to 5 nM, whereas the initial K i s for cathepsin H and L are about 40-200 μM. CA-074 exhibits 10000-30000 times greater inhibitory effects on purified rat cathepsin B than on cathepsin H and L. |
In vivo study | Intraperitoneally injection of compound CA-074 into rats potently and selectively inhibits cathepsin B activity. Intravenously administration of CA-074 immediately after the ischaemic insult saves 67% of CA1 neurons from delayed neuronal death on day 5 in eight monkeys undergoing 20 min brain ischaemia: the extent of inhibition is excellent in three of eight and good in five of eight monkeys. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.608 ml | 13.04 ml | 26.08 ml |
5 mM | 0.522 ml | 2.608 ml | 5.216 ml |
10 mM | 0.261 ml | 1.304 ml | 2.608 ml |
5 mM | 0.052 ml | 0.261 ml | 0.522 ml |
biological activity | CA-074 is a potent inhibitor of cathepsin B with Ki values of 2 to 5 nM. |
Target | Ki: 2 to 5 nM (Cathepsin B) |